ESR1 and neoplasm: In a recent study [93], carried out with a rat model with ER+ MCF-7 tumor xenografts, LAN not only increased the rate of tumor development but also conferred resistance to tamoxifen therapy as well as to chemotherapeutic treatment with doxorubicin [94].